News : pharmaceutical

VectorBuilder and Landau enter into strategic partnership to establish world’s first primate gene therapy R&D center. more...
Validair Monitoring Solutions has announced it will be supplying a TSI AeroTrak 9110-01 Airborne particle Counter for use in a newly designed isolator at the University of Leicester for its Life-on-Mars project.  more...
Untidy biological safety cabinet
Every biological safety cabinet The Baker Company builds ensures that you can work in safety - with confidence.  Download your free poster and create a safe working environment in your biological safety cabinet. more...
The ECDC has released a technical report on the need for COVID-19 vaccine boosters shots and have concluded there is no urgent need for the general population.  more...
Sino Biological on Stock Exchange
Sino Biological has announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047. A total of 17 million shares were issued for a total of 4.98 billion RMB raised during this initial public offering.  more...
In order to support the fight against Lambda variants, ACROBiosystems rapidly developed the recombinant S and N antigens with the Lambda mutations with high purity (more than 90%). more...
Pall QC Filtration for viruses product line
In this interview with Kacey Pouliot (Global Product Manager, PALL), she discusses the membrane filtration method's popularity, how user-friendly design of filtration systems can avoid contamination and what makes a high-performance membrane.  more...
SAS Super Duo 360 portable microbial air samplers
Cherwell Laboratories has recently delivered its biggest-ever single order for microbial air sampling equipment to support the large-scale manufacturing programme for COVID-19 vaccine supply. more...
Antibodies for Influenza Antigen Test
Sino Biological has identified six Pan antibody pairs with high sensitivity (pg level) against the NP protein of Influenza A and Influenza B. They also demonstrate broad reactivity against a large cohort of flu strains. more...
VectorBuilder and Univercells logos
VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and gene therapies, as well as vaccine applications. more...
Nano Molecularly imprinted polymers for use in rapid antigen tests for COVID-19
MIP Diagnostics' COVID-19 nanoMIP has been shown to outperform a commercial antibody in a sensor platform, with 20x improvement in sensitivity. more...
Vibalogics Viral vector manufacturing facility
Vibalogics, a global contract development and manufacturing organization (CDMO), has announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity. more...
Recombinant viral antigen collecting including coronavirus
Sino Biological has developed the world's largest recombinant viral antigen collection, ProVir™, which features an exclusive coronavirus catalog, a comprehensive collection of influenza antigens, and many other hard-to-find viral proteins such as Zika, RSV, Ebola, and Cytomegalovirus. more...
Recombinant Adeno-Associated Virus-Based Vectors
Biogen and Ginkgo are collaborating to improve the efficiency of AAV-producing plasmid vectors and cell lines for cell and gene therapy applications. Under the terms of the agreement, Biogen will receive access to Ginkgo’s proprietary cell programming platform and capabilities. more...
Virucidal Efficacy Testing
Eurofins BioPharma Product Testing Italy (Eurofins BTP Italy) has expanded its virucidal testing capacity with the opening of a dedicated laboratory. The laboratory will carry out testing and studies on disinfectant products to meet growing demand in the wake of the COVID-19 pandemic. more...
SARS-CoV-2 mutation analysis
baseclick has developed a new and more efficient process to determine predominant and minor mutations in the SARS-CoV-2 virus population which might eventually become new strains. more...